Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non–Small Cell Lung Cancer: Systematic Review and Meta-Analysis
Journal of Medical Internet Research · 13.08.2026 · 28 · e93892-e93892
DOI: 10.2196/93892 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Medical Internet Research, online erschienen am 13.08.2026. Verfasst von Ziqi Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No.1 Shuaifuyuan, Wangfujing, Beijing, Don…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Radiomics, Lung Neoplasms, Neoadjuvant Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Non–small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide. Accurate early prediction of response to neoadjuvant therapy is critical.
Objective
We aimed to evaluate the diagnostic performance of radiomics-based AI in predicting pathological complete response (pCR) and major pathological response (MPR) following neoadjuvant immunochemotherapy in NSCLC and to compare it against traditional radiological criteria.
Methods
A systematic search of PubMed, Embase, Cochrane Library, and Web of Science was conducted through October 26, 2025. Studies utilizing computed tomography (CT) or positron emission tomography/CT-based AI models to predict pCR or MPR were included. Methodological quality was appraised using the PROBAST (Prediction Model Risk of Bias Assessment Tool)+AI tool. Sensitivity, specificity, and area under the curve (AUC) were pooled using a bivariate random effects model.
Results
Twenty-three studies involving 2004 patients in validation sets were included, with histopathology as the gold standard. For pCR, AI models achieved a pooled sensitivity of 0.77 (95% CI 0.70‐0.83), specificity of 0.79 (95% CI 0.73‐0.84), and AUC of 0.85, significantly outperforming traditional criteria in sensitivity (0.77 vs 0.42; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No.1 Shuaifuyuan, Wangfujing, Beijing, Dongcheng District, 100730, China, 86 13621021237.
- Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zitieren
APA
Jiang, Z., Xu, Y., Jia, S., & Liu, H. (2026). Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non–Small Cell Lung Cancer: Systematic Review and Meta-Analysis. Journal of Medical Internet Research, 28, e93892-e93892. https://doi.org/10.2196/93892
Vancouver
Jiang Z, Xu Y, Jia S, Liu H. Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non–Small Cell Lung Cancer: Systematic Review and Meta-Analysis. Journal of Medical Internet Research. 2026;28:e93892-e93892. doi:10.2196/93892
BibTeX
@article{Jiang2026,
author = {Jiang, Ziqi and Xu, Yuan and Jia, Shuyu and Liu, Hongsheng},
title = {Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non–Small Cell Lung Cancer: Systematic Review and Meta-Analysis},
journal = {Journal of Medical Internet Research},
year = {2026},
volume = {28},
pages = {e93892--e93892},
doi = {10.2196/93892}
}
EUVIMED